Article Details

Puma's Positive Neratinib Data, And Other News: The Good, Bad Ugly Of Biopharma

Retrieved on: 2020-10-08 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

Puma's Positive Neratinib Data, And Other News: The Good, Bad Ugly Of Biopharma. View article details on HISWAI:

Excerpt

<div>Puma <b>Biotechnology</b> reports positive Neratinib Phase III data. Y-mAbs Therapeutics receives FDA rejection for omburtamab BLA. Halozyme ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up